Table 2 Treatment of pregnant women with pulmonary hypertension in pre- MDT and post-MDT groups
Pre-MDT (n = 49) | Post-MDT (n = 54) | p value | ||||
|---|---|---|---|---|---|---|
n | % | n | % | |||
Pulmonary-specific therapy | 8 | 24.2% | 222 | 59.5% | < 0.01 | |
Monotherapy | 7 | 12 | ||||
Combination therapy | 1 | 10 | ||||
Oxygen therapy | 34 | 69.4% | 32 | 59.3% | NS | |
Diuretic | 20 | 40.8% | 21 | 38.9% | NS | |
Digoxin or Cedilan | 18 | 36.9% | 16 | 29.6% | NS | |
Mode of deliverya | NS | |||||
Vaginal | 2 | 4.2% | 1 | 1.9% | ||
Cesarean section | 46 | 95.8% | 53 | 98.1% | ||
Anesthesiaa,b | < 0.01 | |||||
General anesthesia | 18 | 39.1% | 38 | 71.7% | ||
Neuraxialc | 28 | 60.9% | 15 | 28.3% | ||
Monitored in ICUd | 20 | 40.8% | 43 | 79.6% | < 0.01 |